Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis

Conditions:   Hepatitis B;   Cirrhosis, Liver;   Chronic Liver Disease Interventions:   Biological: Heplisav-B Injectable Product, 2-dose regimen;   Biological: Heplisav-B Injectable Product, 3-dose regimen Sponsor:   Mercy Medical Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials